Evidence map›Paper›PMID 36263238›Full record

Observational studyInternational journal of clinical practice2022

Does Rocuroinum Dose Adjusted Due to Lean Body Weight Provide Adequate Intubation Conditions?: A Prospective Observational Study.

Duygu Demiroz, Yusuf Ziya Colak, Sumeyye Koc Iclek, Mehmet Ali Erdogan, Neslihan Altunkaya Yagci, Mahmut Durmus, Nurcın Gulhas

Registry-linked trialAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05476952 (The Effect of Lean Body Weight-adjusted Rocuronium Dose on Intubation Conditions), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05476952 completednot on this mapstarted 2023, after this paper: background citation

The Effect of Lean Body Weight-adjusted Rocuronium Dose on Intubation Conditions: a Prospective Observational Study

TypeobservationalSponsorDUYGU DEMİROZRan2023 to 2023Enrolled180ConditionsBody Weight Changes, Rocuronium, Intubation ConditionsArmshe patients who are administered rocuronium according to LBW were categorized as "LBW", and The group number for those administer according to TBW was categorized as "K".
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Duygu DemirozInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-4241-4514
Yusuf Ziya ColakInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-8729-8705
Sumeyye Koc IclekInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-6001-9075
Mehmet Ali ErdoganInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-3860-6919
Neslihan Altunkaya YagciInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-1004-4889
Mahmut DurmusBezmialem Foundation University Medical Faculty Hospital, Department of Anesthesiology and Reanimation, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-9594-9064
Nurcın GulhasInonu University, School of Medicine, Department of Anesthesiology and Reanimation, Malatya, Turkey.ORCID https://orcid.org/0000-0002-2539-9017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods: This is a prospective, observational study. Patients between the ages of 18 and 65 with BMI of 18.5-34.9, who are expected to be under general anesthesia for less than 6 hours, were divided into 3 groups according to their BMI (Group 1 BMI = 18.5-24.9, Group 2 BMI = 25-29.9, Group 3 BMI = 30-34.9). These groups were randomly divided into 2 subgroups: Groups LBW; 1 LBW, 2 LBW, and 3 LBW were given rocuronium intubation dosages based on their LBW while control groups; 1K, 2K, and 3K were given 0.6 mg/kg rocuronium according to their total body weight. The data on the duration of action of rocuronium and its effects on the endotracheal intubation conditions were evaluated. Results: In Group 1, Conclusion: In adult patients with a BMI of 18.5 and 24.9 BMI, we report optimal intubation conditions with the LBW-adjusted rocuronium dosage. This trial is registered with NCT05476952.

Indexed as

AndrostanolsNeuromuscular Nondepolarizing AgentsAdolescentAdultAgedBody WeightHumansIntubation, IntratrachealMiddle AgedRocuroniumYoung AdultAndrostanolsNeuromuscular Nondepolarizing AgentsRocuronium

Identifiers

PMID36263238
PMCPMC9556254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.